Cargando…
Decitabine combined with CAG regimen in the treatment of elderly patients with acute myeloid leukemia
OBJECTIVE: To analyze the efficacy and safety of decitabine combined with CAG ((cytarabine + aclacinomycin + granulocyte colony stimulating factor)) regimen and CAG regimen alone in the treatment of elderly acute myeloid leukemia. METHODS: 96 elderly patients with acute myeloid leukemia who were adm...
Autores principales: | Zhao, Haitao, Wang, Chunyan, Yu, Fengying, Guo, Qingwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Professional Medical Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6994887/ https://www.ncbi.nlm.nih.gov/pubmed/32063948 http://dx.doi.org/10.12669/pjms.36.2.850 |
Ejemplares similares
-
Decitabine in the treatment of acute myeloid leukemia in elderly patients
por: Malik, Priya, et al.
Publicado: (2014) -
Decitabine combined with CAG for the treatment of atypical chronic myeloid leukemia: a case report and literature review
por: Cheng, Juan, et al.
Publicado: (2020) -
Venetoclax with decitabine versus decitabine monotherapy in elderly acute myeloid leukemia: a propensity score-matched analysis
por: Kwag, Daehun, et al.
Publicado: (2022) -
Pembrolizumab and decitabine for refractory or relapsed acute myeloid leukemia
por: Goswami, Meghali, et al.
Publicado: (2022) -
Successful management of acute myeloid leukemia transformed from chronic myelomonocytic leukemia in the elderly by a combination regimen of decitabine and cytarabine, aclarubicin and granulocyte colony-stimulating factor: A case report
por: DENG, QI, et al.
Publicado: (2015)